Björn Rissiek

@brissiek.bsky.social

Immunologist at the Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf in Hamburg, Germany. Does Nanobody Discovery, interested in neuroinflammation and purinergic signalling. My opinion are my own.

Great news: Our project „ARCH – Alpaca Repertoire Collection of HCAbs“ has been awarded funding through the UKE 3R program. Over the next two years, we will visit alpaca farms across Germany to collect blood and establish a naïve VHH library as a longterm 3R resource for nanobody discovery. #3R #VHH

Bild

Last year, my group launched a project funded by the T. von Zastrow Foundation that truly took all of us into new territory: the establishment of our own #Nanobody Discovery Platform. We genuinely started from scratch – including setting up our own alpaca facility with five female alpacas…

Bild

Yesterday, our first immunization campaign finished. We started late (and finished at 2:00 am 🤯) but everything went well. Lots of PBMCs and good RNA yield 🥳. Big thx to our campaign front runners Gaby 🦙 and Justy 🦙

BildBild

Our alpaca mares have their summer coat since yesterday. Ethics are approved, antigen production is ongoing, and we hope to start the first round of immunization in July. Super excited!!! 🦙🧬🔬👨‍🔬

BildBild

I received one of the 232 NIH grant "terminations" sent to scientists at Columbia last night. My research focuses on improving maternal and child health in the US. Also affected: ongoing clinical trials, research training programs, and research centers that aim to improve the health of Americans.

Hundreds of research grants at Columbia canceled following Trump edict, administrator says

The National Institutes of Health is terminating 232 grants for scientific research at Columbia University Irving Medical Center, according to an email an administrator sent to faculty.

gothamist.com

Texas measles outbreak update: 124 cases, 18 hospitalized, & now the first death of a child, who was not vaccinated. Tragic, preventable, & a direct consequence of the deadly lies spread by anti-vaxx grifters, one of whom is now the most powerful health official in the US.

Texas announces first death in measles outbreak
The Texas Department of State Health Services is reporting the first death from measles in the ongoing outbreak in the South Plains and Panhandle regions.
The school-aged child who was not vaccinated was hospitalized in Lubbock last week and tested positive for measles.
As of Feb. 25, 124 cases of measles have been confirmed in the outbreak since late January. Most of the cases are in children. Eighteen people have been hospitalized over the course of the outbreak.

Come and join our team at St. Jude Children's Research Hospital! We are seeking a Sr Scientist to advance our research on immune responses to infection/vaccination. This is a financially stable position offering a highly competitive salary and excellent benefits. talent.stjude.org/careers/jobs...

Senior Scientist-Immunology, Vaccinology, Infection in Memphis, Tennessee | St. Jude Careers

St. Jude Careers is hiring a Senior Scientist-Immunology, Vaccinology, Infection in Memphis, Tennessee. Review all of the job details and apply today!

talent.stjude.org

New approach: Nanobody inhibitors that target Ebolavirus are under development at Univ of Minnesota. Nanobodies are tiny antibodies from animals like alpacas allowing access to viral regions too small for larger antibodies. This one blocks EBV's ability to enter human cells phys.org/news/2025-01...

Scientists develop nanobody inhibitors to target deadly Ebola virus

Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and safety. To address this challenge, researchers at the University of Minnesot...

phys.org